Fate Therapeutics Inc
XBER:F6T
Fate Therapeutics Inc
XBER:F6T
Price:
0.8182
EUR
Market Closed
Market Cap:
€959.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Fate Therapeutics Inc
XBER:F6T
|
US |
|
P
|
PIE Co Ltd
KOSDAQ:452450
|
KR |
|
W
|
Wilmar Cahaya Indonesia Tbk PT
IDX:CEKA
|
ID |
|
E
|
EMCORE Corp
F:ER2N
|
US |
|
M
|
Matsui Construction Co Ltd
TSE:1810
|
JP |
|
S
|
scPharmaceuticals Inc
F:2SX
|
US |
|
M
|
Montage Gold Corp
OTC:MAUTF
|
CA |
|
N
|
NE Neungyule Inc
KOSDAQ:053290
|
KR |
|
T
|
Turbon AG
XMUN:TUR
|
DE |
|
IRPC PCL
OTC:IRPSY
|
TH |
Wall St Price Targets
F6T Price Targets Summary
Fate Therapeutics Inc
Fate Therapeutics Inc
Wall Street analysts forecast F6T stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for F6T is 1.9111 EUR with a low forecast of 0.7451 EUR and a high forecast of 2.8168 EUR.
Lowest Forecast
Price Target
0.7451
EUR
9% Downside
Average Forecast
Price Target
1.9111
EUR
134% Upside
Highest Forecast
Price Target
2.8168
EUR
244% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is F6T's stock price target?
Price Target
1.9111
EUR
1.9111
EUR
According to Wall Street analysts, the average 1-year price target for F6T is 1.9111 EUR with a low forecast of 0.7451 EUR and a high forecast of 2.8168 EUR.
What is the Revenue forecast for Fate Therapeutics Inc?
Projected CAGR
70%
70%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 70%.
